GlassScriptPhysician profile
John D Horgan
NPI 1568465680
$10,093.52
in general payments reported to CMS, 2019-2025
49 companies · $1,431 in 2025
The $1,431 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,766 · 2020: $697 · 2021: $1,570 · 2022: $1,797 · 2023: $1,682 · 2024: $1,150 · 2025: $1,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,029 · Education: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,029.00 |
| Education | $233.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,425.02 | 2019-2025 | Erleada, Akeega |
| Teleflex LLC | $1,221.50 | 2021-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $881.87 | 2023-2025 | Orgovyx, Gemtesa, Myfembree |
| Astellas Pharma US INC | $847.42 | 2019-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $658.56 | 2019-2024 | |
| Boston Scientific Corporation | $564.57 | 2019-2023 | Spaceoar Vue System - 10ml, Rezum Generator |
| Dendreon Pharmaceuticals LLC | $503.12 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $352.07 | 2019-2025 | |
| Urogen Pharma, INC. | $280.31 | 2021-2025 | Jelmyto |
| Coloplast Corp | $278.35 | 2021-2024 | Porges Coloplast |
| Neotract INC. | $219.95 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $213.21 | 2021-2023 | Prolaris |
| Pfizer INC. | $205.41 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $174.68 | 2025 | Lynparza |
| Myovant Sciences INC. | $174.04 | 2021-2022 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $159.24 | 2023-2024 | Trelstar |
| Sun Pharmaceutical Industries INC. | $141.11 | 2019-2025 | |
| Immunitybio, INC. | $135.37 | 2025 | |
| Urovant Sciences INC | $132.51 | 2021-2022 | |
| Axonics, INC. | $121.40 | 2020-2023 | Axonics |
| Ferring Pharmaceuticals INC. | $112.00 | 2024-2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $102.12 | 2021-2024 | Keytruda, Lynparza, Welireg |
| Seagen INC. | $99.99 | 2025 | |
| Novartis Pharmaceuticals Corporation | $98.96 | 2022-2025 | |
| Tolmar Pharmaceuticals, INC. | $96.95 | 2022 | |
| Amgen INC. | $94.45 | 2019-2023 | Xgeva |
| Endo Pharmaceuticals INC. | $92.59 | 2019-2022 | |
| Blue Earth Diagnostics | $83.22 | 2019-2023 | |
| Dornier Medtech America, INC | $75.20 | 2019-2020 | |
| Tolmar, INC. | $64.08 | 2023-2025 | Eligard, Jatenzo |
| Edap Technomed INC | $63.00 | 2024 | |
| Medtronic USA, INC. | $61.23 | 2019 | |
| Antares Pharma, INC. | $56.82 | 2020-2022 | |
| Medtronic, INC. | $46.63 | 2024-2025 | Interstim |
| Karl Storz Endoscopy-America | $22.94 | 2020 | |
| Integra Lifesciences Corporation | $22.86 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Accord Healthcare, INC. | $21.21 | 2023 | |
| Foundation Medicine, INC. | $21.11 | 2023 | Foundationone Cdx |
| Travere Therapeutics, INC. | $20.46 | 2021 | |
| Alnylam Pharmaceuticals INC. | $19.48 | 2025 | Givlaari |
| Cook Medical LLC | $16.90 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.72 | 2022 | |
| 180 Medical, INC. | $15.47 | 2019 | |
| Olympus America INC. | $15.11 | 2025 | Itind System |
| Clinigen, INC. | $14.60 | 2020 | |
| Telix Pharmaceuticals | $13.07 | 2023 | Illuccix |
| Medline Industries LP | $13.01 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $12.49 | 2019 | |
| Allergan, INC. | $12.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Horgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.